Optimize end-to-end visibility

Integration as the key to visibility

OMP for Life Sciences uses Unison Planning™ to build a digital twin of your entire extended supply chain ecosystem. Its ‘one model, one plan’ logic provides an integrated platform allowing every stakeholder to act and react to real-time information and harmonize planning decisions with all the players involved.

Seamlessly integrating every planning horizon, function, and role means that planning is optimized from production, detailed scheduling, sales & operations, to the strategy. It offers a global and facility-specific perspective on internal and external production, packaging, and distribution, considering all the inherent interdependencies and underlying constraints, such as shelf life and regulatory approvals. Thanks to the integrated platform, every stakeholder in the value chain has access to reliable, objective, and real-time planning data.

Perfect visibility

Global E2E visibility not only gives decision makers full control over the entire supply chain ecosystem but also represents the perfect tool to manage and coordinate every aspect. With its integrated logic, OMP for Life Sciences eliminates disconnects between planning horizons, allowing optimization at a global level, and avoiding the risks inherent in making decisions with only partial supply chain visibility.

The system’s real-life integration, in combination with advanced embedded intelligence, puts you in the driver’s seat. Always knowing what’s happening right now allows you to react faster and more accurately. The AI backbone triggers you to make the smartest possible decisions, and propagates its impact through every planning level, making any change instantly visible to everyone involved. As a bonus, the flexibility of the underlying architecture supports an endless array of supply chain types and strategies, from traditional mass pharma to more specialized scenarios such as personalized therapies.

Superior availability and optimized profits

In addition to end-to-end visibility throughout the value chain, OMP for Life Sciences intelligently adjusts production, packaging, and distribution lines, capacities, and networks. All this while optimizing inventory levels of intermediate and finished products as well as synchronizing manufacturing equipment and packaging lines.

The availability of capacity constraint solvers, in combination with self-learning data, advanced data management, and integration features, all guarantee a perfect sync between plan and reality,  making planning outcomes both realistic and feasible. Decision makers can react faster and with greater precision to unexpected disruptions in demand and supply, improving responsiveness and managing risk.

Gaining control with targeted functionalities

But OMP for Life Sciences has even more to offer. Its attribute-based planning options, for example, allow decision makers to plan for specific batch characteristics and shelf life requirements, instead of planning on materials alone.

Pegging functionality lets you peg any demand and supply element according to the various rules integrated within the model, including regulatory constraints, quantity tolerance, and shelf-life. Pegging can also be applied retroactively by tracing and recording the origin of every batch produced, providing end-to-end visibility over internal and external networks, from the drug substance and its components to the demand.

 AI, solvers, ML, and data science can all be used to assess the impact of predicted or unexpected demand shocks, supply disruptions, batch contamination, production incidents, packaging errors, and logistics issues. They can also support you in developing and evaluating smart alternative solutions and scenarios to better anticipate or respond to such events.

Production meets regulation

OMP for Life Sciences treats handled regulatory issues as an additional planning constraint, taking into account which in-house or CMO facilities are authorized to produce a particular drug substance for specific customer segments and regions, and in the specified time frame.

This makes it easier to adapt and optimize your planning in response to new approvals (or disqualifications) following inspections by regulatory authorities. It also offers the ideal collaboration platform for S&OP and regulatory approval teams to share input and co-develop alternative scenarios in response to expected (or delayed) approval dates. From the strategic to the operational level, it takes into account the available production capacity at every node in your supply chain ecosystem.

Aligning with quality assurance and quality control

To boost collaboration between production, and quality assurance and control, OMP for Life Sciences empowers planners and schedulers to take into account throughput times for quality controls. This makes it possible to attribute priorities to urgent batches and get them tested first, to meet critical deadlines, or to prioritize key customers.

Balancing clinical and commercial production

OMP for Life Sciences breaks down the wall between clinical and commercial products to achieve optimal trade-offs and smooth the research and product launch process. You can, for example, more easily anticipate patent approval to plan commercial production and distribution networks well in advance.

The collaborative portal offers intuitive visualization of both clinical and commercial capacity planning. You can orchestrate both at once, even when clinical and commercial production use the same equipment product lines, or reactors, or where products have been commercially approved for selected indications or patient groups, but may still be at an earlier clinical trial phase for others.